APIDRA 100 UI/ML SOL INJ CT 1 FA VD INC X 10 ML

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1832603430011
  • GGREM 576720020052217
  • Código de barras 7891058027117

O que a fonte publica

Detentor do registro
SANOFI MEDLEY FARMACÊUTICA LTDA.
Princípios ativos
INSULINA GLULISINA
Embalagem
100 UI/ML SOL INJ CT 1 FA VD INC X 10 ML
Tipo de produto
Biológico
Classe terapêutica
A10C1 - Insulinas humanas e análogos, ação rápida

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:576720020052217
{
  "name": "APIDRA 100 UI/ML SOL INJ CT 1 FA VD INC X 10 ML",
  "holder": "SANOFI MEDLEY FARMACÊUTICA LTDA.",
  "stripe": null,
  "barcodes": [
    "7891058027117"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "576720020052217",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "10.588.595/0010-92",
  "priceRegime": "Regulado",
  "productName": "APIDRA",
  "productType": "Biológico",
  "hospitalOnly": false,
  "presentation": "100 UI/ML SOL INJ CT 1 FA VD INC X 10 ML",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "98.31",
    "icms-12": "111.72",
    "icms-17": "118.45",
    "icms-18": "119.89",
    "icms-19": "121.37",
    "icms-20": "122.89",
    "icms-21": "124.44",
    "icms-22": "126.04",
    "icms-23": "127.68",
    "icms-17.5": "119.16",
    "icms-19.5": "122.12",
    "icms-20.5": "123.66",
    "icms-22.5": "126.85",
    "icms-12-alc": "110.38",
    "icms-17-alc": "117.02",
    "icms-18-alc": "118.45",
    "icms-19-alc": "119.91",
    "icms-20-alc": "121.41",
    "icms-21-alc": "122.95",
    "icms-22-alc": "124.53",
    "icms-23-alc": "126.14",
    "withoutTaxes": "97.13",
    "icms-17.5-alc": "117.73",
    "icms-19.5-alc": "120.66",
    "icms-20.5-alc": "122.18",
    "icms-22.5-alc": "125.33"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "INSULINA GLULISINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "135.51",
    "icms-12": "153.99",
    "icms-17": "163.27",
    "icms-18": "165.26",
    "icms-19": "167.30",
    "icms-20": "169.39",
    "icms-21": "171.53",
    "icms-22": "173.73",
    "icms-23": "175.99",
    "icms-17.5": "164.25",
    "icms-19.5": "168.33",
    "icms-20.5": "170.45",
    "icms-22.5": "174.85",
    "icms-12-alc": "152.59",
    "icms-17-alc": "161.77",
    "icms-18-alc": "163.75",
    "icms-19-alc": "165.77",
    "icms-20-alc": "167.84",
    "icms-21-alc": "169.97",
    "icms-22-alc": "172.16",
    "icms-23-alc": "174.38",
    "withoutTaxes": "134.28",
    "icms-17.5-alc": "162.75",
    "icms-19.5-alc": "166.81",
    "icms-20.5-alc": "168.91",
    "icms-22.5-alc": "173.26"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "INSULINA GLULISINA"
  ],
  "therapeuticClass": "A10C1 - Insulinas humanas e análogos, ação rápida",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1832603430011",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "A10C1",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:576720020052217"